<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2340-9894</journal-id>
<journal-title><![CDATA[Ars Pharmaceutica (Internet)]]></journal-title>
<abbrev-journal-title><![CDATA[Ars Pharm]]></abbrev-journal-title>
<issn>2340-9894</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2340-98942025000300373</article-id>
<article-id pub-id-type="doi">10.30827/ars.v66i3.33139</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Protocolo de revisión sistemática y metaanálisis de los tratamientos biológicos y sintéticos en artritis psoriásica refractaria]]></article-title>
<article-title xml:lang="en"><![CDATA[Protocol for systematic review and meta-analysis of biologic and synthetic treatments in refractory psoriatic arthritis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Domínguez-Santana]]></surname>
<given-names><![CDATA[Carmen María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fénix-Caballero]]></surname>
<given-names><![CDATA[Silvia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cano-Martínez]]></surname>
<given-names><![CDATA[Gala]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alegre-del-Rey]]></surname>
<given-names><![CDATA[Emilio Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martín-Ruiz]]></surname>
<given-names><![CDATA[Eva]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olry de Labry-Lima]]></surname>
<given-names><![CDATA[Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A4"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Ribera Povisa Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Vigo ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario de Puerto Real Farmacia Hospitalaria ]]></institution>
<addr-line><![CDATA[Puerto Real Andalucía]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Sevilla Facultad de Enfermería, Fisioterapia y podología Departamento de Enfermería]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Escuela Andaluza de Salud Pública  ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Escuela Andaluza de Salud Pública Centro Andaluz de Documentación e Información de Medicamentos (CADIME) ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,CIBER en Epidemiología y Salud Pública (CIBERESP)  ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2025</year>
</pub-date>
<volume>66</volume>
<numero>3</numero>
<fpage>373</fpage>
<lpage>384</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2340-98942025000300373&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2340-98942025000300373&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2340-98942025000300373&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  La artritis psoriásica es una enfermedad inflamatoria crónica con variedad de manifestaciones en articulaciones, piel y otros tejidos. En los últimos años, se han comercializado diferentes terapias para pacientes refractarios; no se dispone de comparaciones directas entre la mayoría de los tratamientos, lo cual dificulta la toma de decisiones clínicas para la elección del mismo. Por ello, se plantea comparar la eficacia y seguridad de los distintos tratamientos para la artritis psoriásica activa y analizar posibles diferencias por subgrupos según tratamiento biológico previo.  Método:  Se realizará una revisión sistemática y un metaanálisis en red. La información de los ensayos clínicos en fase II o III relevantes se recuperará de las bases de datos, incluidas PubMed, Cochrane Library, Embase y ClinicalTrials. Se construirá una búsqueda con términos libres y controlados (MeSH y Emtree). La búsqueda manual tratará de encontrar otros informes no publicados y datos complementarios. Los datos se extraerán mediante una hoja de volcado de datos diseñada ad hoc. Se utilizará la herramienta de riesgo de sesgo avaladas por Cochrane de los estudios incluidos. Se realizará un metaanálisis en red para comparar la proporción de pacientes que alcanzaron una tasa de mejora del 50 % en la valoración del American College of Rheumatology (ACR50). La seguridad se evaluará mediante la incidencia de eventos adversos.  Conclusiones:  Los resultados de este metaanálisis contribuirán a la toma de decisiones clínica en torno al uso de los fármacos en el tratamiento de la artritis psoriásica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Psoriatic arthritis (PsA) is a chronic inflammatory disease with a variety of manifestations in joints, skin and other tissues. In recent years, different therapies have been marketed, but direct comparisons between most treatments are not available, which makes clinical decision making difficult in refractory patients, generating high uncertainty. The objective is to compare the efficacy and safety of different treatments for active psoriatic arthritis and to analyze possible differences according to previous treatment.  Methods:  a systematic review and network meta-analysis will be performed following the PRISMA recommendations and their extensions. Information from relevant phase II or III clinical trials will be retrieved from major databases including PubMed, Cochrane Library, Embase, ClinicalTrials.gov and Google Scholar. A search was constructed using both free and controlled terms (MeSH and Emtree), which has been validated by a librarian with extensive experience. Google and manual search will find other unpublished reports and supplementary data. Data will be extracted using an ad hoc designed data dump sheet. The Cochrane risk of bias tool will be used to assess the quality of clinical trials. Finally, a network meta-analysis will be performed to compare the proportion of patients who achieved a 50 % improvement rate on the American College of Rheumatology (ACR50) assessment. Safety will be assessed by the incidence of adverse events.  Conclusions: The results of this meta-analysis may be important for health personnel and health policy makers regarding the use of drugs in the treatment of psoriatic arthritis]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[artritis psoriásica]]></kwd>
<kwd lng="es"><![CDATA[tratamiento biológico]]></kwd>
<kwd lng="es"><![CDATA[tratamiento sintético dirigido]]></kwd>
<kwd lng="en"><![CDATA[Psoriatic arthritis]]></kwd>
<kwd lng="en"><![CDATA[biological treatment]]></kwd>
<kwd lng="en"><![CDATA[targeted synthetic treatment]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>International Diabetes Federation (IDF)</collab>
<source><![CDATA[IDF Diabetes Atlas]]></source>
<year>2021</year>
<edition>10th edition</edition>
<publisher-name><![CDATA[International Diabetes Federation]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno Velásquez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Montenegro Mendoza]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Niño Hall]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Motta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes mellitus, its prevalence, awareness, and control in Panama: Data from ENSPA 2019, a national cross-sectional study]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2023</year>
<volume>102</volume>
<numero>32</numero>
<issue>32</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Priorizar el control glucémico temprano para reducir las complicaciones micro y macrovasculares en personas con diabetes tipo 2]]></article-title>
<source><![CDATA[RedGDPS]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holman]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Bethel]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Matthews]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Neil]]></surname>
<given-names><![CDATA[HAW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>359</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1577-89</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rothman]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Malone]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bryant]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Padgett]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[DeWalt]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Spoken Knowledge in Low Literacy in Diabetes scale: a diabetes knowledge scale for vulnerable patients]]></article-title>
<source><![CDATA[Diabetes Educ]]></source>
<year>2005</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>215-24</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jeppesen]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Hull]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Raines]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miser]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A validation study of the spoken knowledge in low literacy in diabetes scale (SKILLD)]]></article-title>
<source><![CDATA[J Gen Intern Med]]></source>
<year>2012</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>207-12</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Zuniga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reynolds]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cairampoma]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sumlin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the spoken knowledge in low literacy in diabetes scale for use with Mexican Americans]]></article-title>
<source><![CDATA[J Transcult Nurs]]></source>
<year>2015</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>279-86</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Amirehsani]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[McCoy]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Coley]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Zhan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reliability and Validity of the Spoken Knowledge in Low Literacy in Diabetes in Measuring Diabetes Knowledge Among Hispanics With Type 2 Diabetes]]></article-title>
<source><![CDATA[Diabetes Educ]]></source>
<year>2020</year>
<volume>46</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>465-74</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<collab>PTS Diagnostics</collab>
<article-title xml:lang=""><![CDATA[A1CNow+ System]]></article-title>
<source><![CDATA[PTS Diagnostics]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes&#8212;2024]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2024</year>
<volume>47</volume>
<numero>Supplement_1</numero>
<issue>Supplement_1</issue>
<page-range>S111</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Streiner]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Norman]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Cairney]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Health measurement scales. A practical guide to their development and use]]></source>
<year>2015</year>
<edition>5th ed.</edition>
<publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeVellis]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<source><![CDATA[Scale Development: Theory and Applications (Applied Social Research Methods)]]></source>
<year>2011</year>
<edition>3rd ed.</edition>
<publisher-loc><![CDATA[Thousand Oaks, CA ]]></publisher-loc>
<publisher-name><![CDATA[SAGE Publications, Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez González]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Villegas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Faulín Fajardo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Bioestadística amigable]]></source>
<year>2006</year>
<edition>2ª ed.</edition>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Díaz de Santos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Rajah]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[SSA]]></given-names>
</name>
<name>
<surname><![CDATA[Karim]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic Review and Meta-Analysis of Diabetes Knowledge among Type 2 Diabetes Patients in Southeast Asia]]></article-title>
<source><![CDATA[Rev Diabet Stud]]></source>
<year>2021</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>82-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Tran]]></surname>
<given-names><![CDATA[TTT]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Diep]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Vo]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Taxis]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized controlled trial of a pharmacist-led intervention to enhance knowledge of Vietnamese patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Int J Pharm Pract]]></source>
<year>2022</year>
<volume>30</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>449-56</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<collab>Sociedad Española de Diabetes</collab>
<article-title xml:lang=""><![CDATA[Programa de educación terapéutica para personas con diabestes tipo 2 y/o familiares y/o cuidadores]]></article-title>
<source><![CDATA[]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ouzzani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hammady]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Fedorowicz]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Elmagarmid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rayyan&#8212;a web and mobile app for systematic reviews]]></article-title>
<source><![CDATA[Syst Rev]]></source>
<year>2016</year>
<volume>5</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alegre Del Rey]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fénix Caballero]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castaño Lara]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra García]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación y posicionamiento de medicamentos como alternativas terapéuticas equivalentes]]></article-title>
<source><![CDATA[Med Clínica]]></source>
<year>2014</year>
<volume>143</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-90</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sterne]]></surname>
<given-names><![CDATA[JAC]]></given-names>
</name>
<name>
<surname><![CDATA[Savovi&#263;]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Elbers]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Blencowe]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[RoB 2: a revised tool for assessing risk of bias in randomised trials]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2019</year>
<volume>366</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conde-Ruiz]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
</person-group>
<source><![CDATA[El proceso de envejecimiento en España]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[FEDEA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Salvar vidas, reducir el gasto: Una respuesta estratégica a las enfermedades no transmisibles]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Ginebra (Suiza) ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<collab>Autoridad Independiente de Reponsabilidad Fiscal</collab>
<article-title xml:lang=""><![CDATA[Evaluación del Gasto Público 2019. Gasto hospitalario del sistema nacional de salud: farmacia e inversión en bienes de equipo]]></article-title>
<source><![CDATA[AIReF]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garjón Parra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación y selección de medicamentos]]></article-title>
<source><![CDATA[Farm Aten Primaria]]></source>
<year>2011</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>89-94</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
